Cargando…
KRIBB11 Induces Apoptosis in A172 Glioblastoma Cells via MULE-Dependent Degradation of MCL-1
KRIBB11, an HSF1 inhibitor, was shown to sensitize various types of cancer cells to treatment with several anticancer drugs. However, the exclusive effects of KRIBB11 in preventing the growth of glioblastoma cells and the related mechanisms have not been elucidated yet. Herein, we aimed to examine t...
Autores principales: | Yoo, Kyunghyun, Yun, Hye-Hyeon, Jung, Soon-Young, Lee, Jeong-Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305965/ https://www.ncbi.nlm.nih.gov/pubmed/34299435 http://dx.doi.org/10.3390/molecules26144165 |
Ejemplares similares
-
Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells
por: Park, Seong Hye, et al.
Publicado: (2016) -
KRIBB11: A Promising Drug that Promotes Microglial Process Elongation and Suppresses Neuroinflammation
por: Su, Jianbin, et al.
Publicado: (2022) -
Heat Shock Factor 1 Depletion Sensitizes A172 Glioblastoma Cells to Temozolomide via Suppression of Cancer Stem Cell-Like Properties
por: Im, Chang-Nim, et al.
Publicado: (2017) -
Reduced association of anti-apoptotic protein Mcl-1 with E3 ligase Mule increases the stability of Mcl-1 in breast cancer cells
por: Pervin, S, et al.
Publicado: (2011) -
Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
por: Murphy, Á. C., et al.
Publicado: (2013)